ISG20 and prostate carcinoma: The results showed that CD increased ISG20 expression at both the protein and mRNA level in a dose-dependent manner in the H1975 lung cancer-cell line ​(Figures 8A, B) and 22RV1 prostate cancer-cell line ​(Figures 8C, D).